Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10287465 | 0.91 | CYP2C9 (0.47) | CYP2C9GAA | |
| SCHEMBL1018332 | 0.91 | CYP2C9 (0.57) | CYP2C9 | |
| SCHEMBL26037123 | 0.90 | CYP2C9 (0.47) | CYP2C9GAA | |
| SCHEMBL26033138 | 0.88 | GAA (0.51) | CYP2C9GAA | |
| SCHEMBL26033688 | 0.87 | GAA (0.64) | CYP2C9GAATRPV1 | |
| SCHEMBL26033703 | 0.87 | CYP2C9 (0.54) | CYP2C9 | |
| SCHEMBL26033721 | 0.85 | CYP2C9 (0.48) | CYP2C9GAA | |
| SCHEMBL26033761 | 0.84 | CYP2C9 (0.51) | CYP2C9 | |
| SCHEMBL26034663 | 0.84 | TRPV1 (0.40) | CYP2C9TRPV1 | |
| SCHEMBL15424117 | 0.83 | CYP2C9 (0.57) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | GENENTECH, INC. (US) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265054-A1 | PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING | SHH, GLI1, SMO | CYP2C9 4725/4885GAA 4713/4885TRPV1 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.